Filing Details
- Accession Number:
- 0001754429-24-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-20 17:10:31
- Reporting Period:
- 2024-08-15
- Accepted Time:
- 2024-08-20 17:10:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1445815 | Bioxytran Inc | BIXT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1166440 | David Platt | 12 Appleton Circle Newton MA 02459 | Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common | Acquisiton | 2024-08-15 | 1,592,921 | $0.12 | 21,675,939 | No | 4 | P | Indirect | by NDPD Pharma |
| Common | Disposition | 2024-08-19 | 21,675,939 | $0.16 | 0 | No | 4 | J | Indirect | by NDPD Pharma |
| Preferred | Acquisiton | 2024-08-19 | 4,335,188 | $0.81 | 4,335,188 | No | 4 | J | Indirect | by NDPD Pharma |
| Preferred | Acquisiton | 2024-08-19 | 8,973,405 | $0.02 | 13,308,593 | No | 4 | C | Indirect | by NDPD Pharma |
| Preferred | Acquisiton | 2024-08-19 | 776,817 | $0.46 | 14,085,410 | No | 4 | J | Indirect | by NDPD Pharma |
| Common | Disposition | 2024-08-19 | 411,300 | $0.00 | 0 | No | 4 | J | Indirect | by Naomi Platt |
| Preferred | Acquisiton | 2024-08-19 | 82,260 | $0.01 | 82,260 | No | 4 | J | Indirect | by Naomi Platt |
| Common | Disposition | 2024-08-19 | 43,027,274 | $0.00 | 0 | No | 4 | J | Direct | |
| Preferred | Acquisiton | 2024-08-19 | 8,605,455 | $0.01 | 8,605,455 | No | 4 | J | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | by NDPD Pharma |
| No | 4 | J | Indirect | by NDPD Pharma |
| No | 4 | J | Indirect | by NDPD Pharma |
| No | 4 | C | Indirect | by NDPD Pharma |
| No | 4 | J | Indirect | by NDPD Pharma |
| No | 4 | J | Indirect | by Naomi Platt |
| No | 4 | J | Indirect | by Naomi Platt |
| No | 4 | J | Direct | |
| No | 4 | J | Direct |
Footnotes
- Total holdings by NDPD Pharma, Inc., an affiliate where the beneficial ownership includes the Companys officers, have been consolidated as indirect ownership in Davis Platt's filing.
- A 5:1 exchange by insiders shares of Common Stock (earlier issued under Section 16b-3) into shares of Convertible Preferred Stock with a conversion ratio of 1:5 shares into Common Stock.
- The shares were acquired through conversion of debt, issued under Rule 3(a)(9).
- Total holdings by Naomi Platt, spouse of David Platt.
Billionaire Hedge Funds
